Novartis Poised for Growth as CEO Hands Baton to Successor Post author:Sam Post published:January 23, 2018 Post category:BioPharma Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace You Might Also Like Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017 BioLife Solutions, Inc. Announces Q1 2017 Financial Results May 11, 2017 Capital Increase In Bavarian Nordic As A Result Of Employee Warrant Exercise May 17, 2017
Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017
